Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer With Bone Metastasis”

197 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 197 results

Post-approval studies (Phase 4)Study completedNCT01129336
What this trial is testing

Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients

Who this might be right for
First or Second Line HER2-negative Breast CancerMetastatic Disease Without Bone Metastasis
Novartis Pharmaceuticals 44
Not applicableStudy completedNCT02553850
What this trial is testing

An Observational Study in Patients With Breast Cancer and Bone Metastases Receiving Ibandronate (Bondronat)

Who this might be right for
Breast Cancer
Hoffmann-La Roche 442
Not applicableEnded earlyNCT01975597
What this trial is testing

Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
University of Michigan Rogel Cancer Center 8
Early research (Phase 1)Temporarily pausedNCT05958199
What this trial is testing

NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 131
Not applicableUnknownNCT00682253
What this trial is testing

Use of Bone Scintigraphy, CT and MRI in Breast Cancer

Who this might be right for
Breast Neoplasms
University of Aarhus 180
Not applicableLooking for participantsNCT07173868
What this trial is testing

FDG PET-CT in Advanced Breast Cancer

Who this might be right for
Histologically Confirmed Metastatic or Locally Advanced Breast Cancer With no Radical Topical Treatment AvailableIf There is Liver Metastasis, Which the Researcher Believes Will be Difficult to Evaluate the Response Accurately With Bone Metastasis or CT
Samsung Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT01441947
What this trial is testing

Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer

Who this might be right for
Breast Cancer
Massachusetts General Hospital 68
Large-scale testing (Phase 3)Active Not RecruitingNCT02051218
What this trial is testing

Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

Who this might be right for
Metastatic Breast CancerMetastatic Prostate CancerBone Metastases
Swiss Cancer Institute 1,380
Early research (Phase 1)Study completedNCT00544804
What this trial is testing

Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2

Who this might be right for
Breast CancerMetastatic Cancer
University of California, San Francisco 41
Testing effectiveness (Phase 2)Study completedNCT01588821
What this trial is testing

Cabozantinib in Advanced Solid Malignancies

Who this might be right for
Lung CancerSolid Tumor (Not Breast or Prostate Cancers)
Massachusetts General Hospital 37
Not applicableStudy completedNCT05049031
What this trial is testing

Impact of Adjuvant Hormone Therapy on Bone and Cardiovascular Risk

Who this might be right for
Breast Cancer
University Hospital, Toulouse 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT04316117
What this trial is testing

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Hormone Receptor Positive Breast CarcinomaMetastatic Breast Carcinoma+1 more
ECOG-ACRIN Cancer Research Group 138
Testing effectiveness (Phase 2)Study completedNCT00558272
What this trial is testing

Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease

Who this might be right for
Breast CancerProstate CancerBone Neoplasms
AstraZeneca 139
Post-approval studies (Phase 4)Study completedNCT00128297
What this trial is testing

Pamidronate Administration in Breast Cancer Patients With Bone Metastases

Who this might be right for
Breast CancerNeoplasm Metastasis
Spanish Breast Cancer Research Group 152
Large-scale testing (Phase 3)Study completedNCT00365105
What this trial is testing

Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer

Who this might be right for
Breast CancerLung CancerMetastatic Cancer+2 more
Radiation Therapy Oncology Group 261
Large-scale testing (Phase 3)Study completedNCT00320710
What this trial is testing

Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 416
Early research (Phase 1)Study completedNCT02223052
What this trial is testing

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Who this might be right for
Hematological NeoplasmsNon-Hodgkin's LymphomaHodgkin's Lymphoma+17 more
Celgene 89
Not applicableUnknownNCT03365973
What this trial is testing

Pathological Fracture in Potentially Unstable Spinal Metastases of Breast Cancer

Who this might be right for
Spinal MetastasesBreast Cancer
Ruijin Hospital 120
Testing effectiveness (Phase 2)Study completedNCT00242203
What this trial is testing

Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer

Who this might be right for
Breast Neoplasms
Washington University School of Medicine 120
Testing effectiveness (Phase 2)WithdrawnNCT00478270
What this trial is testing

Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.

Who this might be right for
PainBone NeoplasmNeoplasm Metastasis
Hoffmann-La Roche
Next Page